期刊文献+

倍他乐克联合胺碘酮治疗快速房颤疗效观察 被引量:5

The effect observation of betaloc combined amiodarone in rapid fibrillation atrial
下载PDF
导出
摘要 目的探讨倍他乐克联合胺碘酮治疗快速心房颤动(房颤)的临床效果。方法将快速房颤患者56例随机分为观察组和对照组,各28例。对照组给予地高辛治疗,观察组给予倍他乐克联合胺碘酮治疗。观察2组卧位心率、血压及复律时间,并比较2组疗效。结果观察组总有效率为96.43%高于对照组的71.43%,差异有统计学意义(P<0.05)。观察组患者卧位心率、收缩压、舒张压及复律时间明显优于对照组,差异有统计学意义(P<0.05)。2组均未见明显的药物不良反应。结论倍他乐克联合胺碘酮治疗快速房颤,复律成功率高,时间短,优于地高辛等常规药物治疗。 Objective To investigate the effect of betaloc combined amiodarone in rapid fibrillation atrial.Methods 58 cases patients with rapid fibrillation atrial were divided into the observation group and the control group,each of 28 cases.The control group received the treatment of digoxin and the observe group received the treatment of betaloc combined amiodarone.Observed supine heart rate,blood pressure and time of sinus rhythm of two groups,and compared the efficacy of two groups.Results The total effective rate of observation group(96.43% ) was higher than that of control group(71.43% ),there had significant difference(P 0.05) .The supine heart rate,systolic blood pressure,diastolic blood pressure and recovery time of observation group was significantly better than that of control group,the difference were statistically significant(P 0.05) .No obvious adverse drug reactions happened.Conclusion Betaloc combined amiodarone treat in rapid atrial fibrillation,cardioversion success rate higher,time shorter,better than digoxin and other conventional drug.
出处 《临床合理用药杂志》 2010年第20期10-11,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 倍他乐克 胺碘酮 地高辛 心房颤动 快速 Betaloc Digoxin Amiodarone Atrial fibrillation rapid
  • 相关文献

参考文献4

二级参考文献11

  • 1曹克将,陈明龙.加强心房颤动的综合治疗[J].中华心血管病杂志,2006,34(8):766-768. 被引量:38
  • 2Gallagher MM.Obel OA.Camm JA.Tachycardia-induced atrialmyopathy:an important mechanism in the pathophysiology of atrial fibrillation[J].J Cardiovasc Electrophysiol,1997,8(9):1065-1074. 被引量:1
  • 3Antman EM, Anbe DT, Armstrong PW,et al.ACC/AHA guidlines for the management of patients with ST-elevation myocardial infarction-executive summary[J]. Circulation,2004,110:588 被引量:1
  • 4Hammill SC.Cardiac arrhythmias[J].JACC,2004,44(suppl 2):16A 被引量:1
  • 5Goldschlager N, Epstein AE, Naccarelli G, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J]. Arch Intern Med,2000,160:1 741 被引量:1
  • 6The American Heart Association in Collaboration with the International Liais on Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 6: Advance cardiovascular life support. Section 5: Phamacology I: Agents for Arrhythmias[J]. Circulation, 2000, 102(Suppl 8): I 112 被引量:1
  • 7Fuster V, Rydén LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation[J]. Eur Heart J,2001,22:1 852 被引量:1
  • 8Khan IA.Pharmacological cardioversion of recent onset atrial fibrillation[J]. Eur Heart J ,2004,25:1 274 被引量:1
  • 9Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation[J]. N Engl J Med, 2002,347:1 825 被引量:1
  • 10黄俊.现代循证心脏病学[M].南京:江苏科技出版社,2002:591-593. 被引量:8

共引文献400

同被引文献32

  • 1戚文航.血管紧张素受体拮抗剂与心房颤动[J].中华心血管病杂志,2004,32(11):1042-1043. 被引量:93
  • 2殷跃辉,刘增长,吴近近,代引,苏立,兰先彬,凌智瑜,杨小渝,罗开良.胺碘酮与氯沙坦、培哚普利联合治疗阵发性心房颤动的前瞻、随机开放研究[J].中华心血管病杂志,2006,34(4):299-302. 被引量:72
  • 3李必祥.心房颤动的药物治疗[J].现代临床医学,2006,32(5):383-384. 被引量:1
  • 4Kumagai K, Nakashima H, Urata H, et al. Effects Of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation [J].J Am Coil Cardiol,2003,41 (12):2197-2204. 被引量:1
  • 5Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation:a prospective and randomizedstudy[J].Circulation,2002,106(3):331-336. 被引量:1
  • 6Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in human [J]. Circulation,2000,101: 2678-2681. 被引量:1
  • 7陈灏珠.内科学[M]第4版[M].北京:人民卫生出版社,1997.224~225. 被引量:28
  • 8中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2010,19(6):701-712. 被引量:6
  • 9Patti G, Chello M, Candura D, et al. Study (atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) fibrillation in patients un- dergoing cardiac surgery : results of the ARMYDA 3 randomized trial ofatorvaststin for reduction of postoperative atrial fibrillation [J]. Circula- tion ,2006 ; 114 : 1455-61,. 被引量:1
  • 10Caballero R, Delpon E, Valenzuela C, et al. Losartan and its metabolite E3174 modify cardiac delayed rectifier K + currents [ J]. Circulation, 2002 ; 101 (10) : 1199. 被引量:1

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部